MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.88
-0.07 (-0.37%)
At close: Jul 6, 2026, 4:00 PM EDT
18.93
+0.05 (0.26%)
After-hours: Jul 6, 2026, 7:46 PM EDT
MoonLake Immunotherapeutics Employees
MoonLake Immunotherapeutics had 130 employees as of December 31, 2025. The number of employees increased by 30 or 30.00% compared to the previous year.
Employees
130
Change (1Y)
30
Growth (1Y)
30.00%
Revenue / Employee
n/a
Profits / Employee
-$1,977,546
Market Cap
1.56B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | 30 | 30.00% |
| Dec 31, 2024 | 100 | 50 | 100.00% |
| Dec 31, 2023 | 50 | 30 | 150.00% |
| Dec 31, 2022 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Maravai LifeSciences Holdings | 416 |
| Vir Biotechnology | 367 |
| Innoviva | 159 |
| MapLight Therapeutics | 133 |
| Septerna | 130 |
MLTX News
- 12 days ago - MoonLake Immunotherapeutics 9M share Secondary priced at $20.00 - TheFly
- 13 days ago - MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering - GlobeNewsWire
- 14 days ago - MoonLake Immunotherapeutics announces $150M offering of Class A ordinary shares - TheFly
- 14 days ago - MoonLake Immunotherapeutics Announces Proposed Public Offering - GlobeNewsWire
- 14 days ago - MoonLake’s SLK has ‘blockbuster potential,’ says Clear Street - TheFly
- 14 days ago - MoonLake Immunotherapeutics Transcript: Investor Day 2026 - Transcripts
- 14 days ago - MoonLake Immunotherapeutics Slides: FY 2026 - Filings
- 15 days ago - MoonLake announces Week 52 results of Phase 3 VELA-1, VELA-2 trials - TheFly